PHARMACOUTILIZATION AND ADHERENCE TO SACUBITRIL/VALSARTAN IN REAL-WORLD: THE REAL.IT STUDY IN HEART FAILURE WITH REDUCED EJECTION FRACTION

被引：0
|
作者：
Iacoviello, M.
Di Gesaro, G.
Sarullo, F.
Miani, D.
Driussi, M.
Correale, M.
Bilato, C.
Passantino, A.
Carluccio, E.
Villani, A.
Esposti, L. Degli
D'Agostino, C.
Peruzzi, E.
Poli, S.
Di Lenarda, A.
机构：
[1] Policlin Riuniti, Foggia, Italy
[2] Arnas PO Civ & Benfratelli, Palermo, Italy
[3] Osped Buccheri Ferla Fatebenefrate, Palermo, Italy
[4] POU Santa Maria Misericordia, Udine, Italy
[5] Osped Civile, Arzignano, Italy
[6] ICS Maugeri Spa Societa Benefit IRCCS B, Bari, Italy
[7] Azienda Osped Perugia, Perugia, Italy
[8] Osped Nuovo Mugello, Borgo San Lorenzo, Italy
[9] ASUGI Trieste, Trieste, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P334
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF
    Iacoviello, Massimo
    Di Gesaro, Gabriele
    Sarullo, Filippo Maria
    Miani, Daniela
    Driussi, Mauro
    Correale, Michele
    Bilato, Claudio
    Passantino, Andrea
    Carluccio, Erberto
    Villani, Alessandra
    degli Esposti, Luca
    d'Agostino, Chiara
    Peruzzi, Elena
    Poli, Simone
    di Lenarda, Andrea
    ESC HEART FAILURE, 2024, 11 (01): : 456 - 465
  • [2] SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION: REAL-WORLD EXPERIENCE FROM ITALY (THE REAL.IT STUDY)
    Di Lenarda, A.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Degli Esposti, L.
    D'Agostino, C.
    Peruzzi, E.
    Monopoli, S.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D134 - D134
  • [3] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)
    Di Lenarda, Andrea
    Di Gesaro, Gabriele
    Sarullo, Filippo Maria
    Miani, Daniela
    Driussi, Mauro
    Correale, Michele
    Bilato, Claudio
    Passantino, Andrea
    Carluccio, Erberto
    Villani, Alessandra
    degli Esposti, Luca
    d'Agostino, Chiara
    Peruzzi, Elena
    Poli, Simone
    Iacoviello, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [4] Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction
    Sarullo, Filippo Maria
    Nugara, Cinzia
    Sarullo, Silvia
    Iacoviello, Massimo
    Di Gesaro, Gabriele
    Miani, Daniela
    Driussi, Mauro
    Correale, Michele
    Bilato, Claudio
    Passantino, Andrea
    Carluccio, Erberto
    Villani, Alessandra
    Degli Esposti, Luca
    D'Agostino, Chiara
    Peruzzi, Elena
    Poli, Simone
    Di Lenarda, Andrea
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [5] Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real-world study
    Wang, Chen
    Lin, Zongwei
    Miao, Dongxia
    Zhang, Hui
    Fu, Kang
    Zhang, Xinyu
    Xiao, Jie
    Hu, Yue
    Sun, Yijun
    Wang, Fen
    Lu, Huixia
    Ji, Xiaoping
    ESC HEART FAILURE, 2023, 10 (03): : 1961 - 1971
  • [6] Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction
    Mapelli, Massimo
    Salvioni, Elisabetta
    de Martino, Fabiana
    Mattavelli, Irene
    Bonomi, Alice
    Sassi, Valentina
    Gugliandolo, Paola
    Vignati, Carlo
    Magini, Alessandra
    Rovai, Sara
    Paolillo, Stefania
    Agostoni, Piergiuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (11) : 882 - 888
  • [7] Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study
    Ganesananthan, Sashiananthan
    Shah, Nisar
    Shah, Parin
    Elsayed, Hossam
    Phillips, Julie
    Parkes, Ann
    Morgan, Angharad
    Yousef, Zaheer
    OPEN HEART, 2020, 7 (02):
  • [8] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [9] Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
    Yang, Ying
    Shen, Chao
    Lu, Jiangting
    Fu, Guosheng
    Xiong, Cui
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 177 - 182
  • [10] Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience
    Ferreira, F. A. C.
    Cristina, S.
    Raposo, A. F.
    Albuquerque, E. M.
    Nabais, I.
    Matias, C. S.
    Nogueira, M. A.
    Vasconcellos, R. C. A.
    Proenca, G. M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 229
12345